Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

CanSino’s Ebola Vaccine Manufacturing Facility, Tianjin

Project Type

Vaccine manufacturing facility

Location

Tianjin, China

Construction Started

October 2015

Expected Completion

September 2018

Estimated Investment

¥2bn ($315m)

Manufacturer

Tianjin CanSino Biotechnology (CanSino)
Expand

Go Top